Time Therapeutics Announces News Release: Preliminary Results of REBRAnD Study, an Investigator-Initiated Clinical Trial for Familial Alzheimer’s Disease by Center for iPS Cell Research and Application (CiRA), Kyoto University; Drug Repositioning of Bromocriptine”